Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer

(2018) Peng Huang et al.   THYROID

Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer

(2018) Yanqiong Zhang et al.   Cell Death & Disease

Long noncoding RNA PANDAR blocks CDKN1A gene transcription by competitive interaction with p53 protein in gastric cancer

(2018) Jun Liu et al.   Cell Death & Disease

Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma

(2018) Yang Yu et al.   Cell Death & Disease

Differential prognostic impact of interleukin-34 mRNA expression and infiltrating immune cell composition in intrinsic breast cancer subtypes

(2018) Karin Zins et al.   Oncotarget

A TP73-AS1/miR-200a/ZEB1 regulating loop promotes breast cancer cell invasion and migration

(2017) Qiongyan Zou et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

(2017) Zefang Tang et al.   NUCLEIC ACIDS RESEARCH

The proto-oncoprotein KR-POK represses transcriptional activation of CDKN1A by MIZ-1 through competitive binding

(2017) K M Lee et al.   ONCOGENE

Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth

(2017) Yu Shi et al.   Nature Communications

P21Waf1/Cip1 plays a critical role in furazolidone-induced apoptosis in HepG2 cells through influencing the caspase-3 activation and ROS generation

(2016) Sijun Deng et al.   FOOD AND CHEMICAL TOXICOLOGY

Role of Chondroitin Sulfate (CS) Modification in the Regulation of Protein-tyrosine Phosphatase Receptor Type Z (PTPRZ) Activity

(2016) Kazuya Kuboyama et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Receptor-Type Protein-Tyrosine Phosphatase ζ and Colony Stimulating Factor-1 Receptor in the Intestine: Cellular Expression and Cytokine- and Chemokine Responses by Interleukin-34 and Colony Stimulating Factor-1

(2016) Stephanie Zwicker et al.   PLoS One

rpL3 promotes the apoptosis of p53 mutated lung cancer cells by down-regulating CBS and NFκB upon 5-FU treatment

(2016) Annapina Russo et al.   Scientific Reports

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis

(2014) Patricia Cortazar et al.   LANCET

LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression

(2014) S Bianco et al.   ONCOGENE

CD147 mediates chemoresistance in breast cancer via ABCG2 by affecting its cellular localization and dimerization

(2013) Shuangyuan Zhou et al.   CANCER LETTERS

Aberrant promoter hypermethylation of p21 (WAF1/CIP1) gene and its impact on expression and role of polymorphism in the risk of breast cancer

(2013) Marjan Askari et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Protein tyrosine phosphatase ζ enhances proliferation by increasing β-catenin nuclear expression in VHL-inactive human renal cell carcinoma cells

(2013) Donghao Shang et al.   WORLD JOURNAL OF UROLOGY

Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy

(2013) P. Godwin et al.   Frontiers in Oncology

NFκB signaling is important for growth of antiestrogen resistant breast cancer cells

(2012) Christina W. Yde et al.   BREAST CANCER RESEARCH AND TREATMENT

Loss of Receptor Protein Tyrosine Phosphatase β/ζ (RPTPβ/ζ) Promotes Prostate Cancer Metastasis

(2012) Zoi Diamantopoulou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY